Table 4 Receiver operating characteristic area under the curve (95% confidence intervals) for prediction of outcome in high risk women, using CVF elafin concentration stratified by gestation at sampling, after exclusion of samples taken once prophylactic intervention had been initiated.
Outcome | Elafin receiver operating characteristic area under the curve (95% confidence interval) | |||
|---|---|---|---|---|
Gestation category (weeks+days) | ||||
10–13+6 | 14–15+6 | 16–19+6 | 20–24+0 | |
Cervical shortening < 25 mm | 0.60 (0.53–0.66) | 0.48 (0.42–0.55) | 0.49 (0.43–0.56) | 0.53 (0.46–0.60) |
sPTB < 37 w | 0.49 (0.42–0.56) | 0.48 (0.41–0.55) | 0.48 (0.41–0.55) | 0.52 (0.44–0.59) |
sPTB < 34 w | 0.63 (0.56–0.70) | 0.61 (0.54–0.67) | 0.57 (0.50–0.63) | 0.64 (0.58–0.71) |
PPROM | 0.54 (0.47–0.61) | 0.52 (0.45–0.59) | 0.49 (0.42–0.56) | 0.61 (0.53–0.67) |
Objective infection | 0.49 (0.42–0.56) | 0.49 (0.42–0.55) | 0.50 (0.43–0.56) | 0.53 (0.46–0.60) |
Fetal adverse outcomes | 0.60 (0.53–0.67) | 0.50 (0.44–0.58) | 0.48 (0.42–0.55) | 0.52 (0.45–0.59) |
